Advertisement
Hospital adoption of procalcitonin testing has had little impact on antibiotic prescribing for chronic obstructive pulmonary disease exacerbations

Procalcitonin Testing Not Impacting Antibiotic Rx for COPD

0
Findings among patients hospitalized for chronic obstructive pulmonary disease exacerbation
The beneficial effects of intensive systolic blood pressure treatment are similar among those with prediabetes and fasting normoglycemia

Intensive Blood Pressure Tx Aids Those With Prediabetes

0
Beneficial effects seen for cardiovascular disease outcomes, all-cause mortality
There does not appear to be significant racial differences in preoperative or intraoperative medication administration for children undergoing emergency appendectomies

Few Racial Differences in Peds Anesthesia Meds Administration

0
Findings after adjustment for age, gender, attending anesthesiologist practice patterns
The cost burden associated with vitiligo is high

Limited Economic Evidence for Vitiligo Treatments

0
Research reveals no evidence to support or refute value for money afforded by vitiligo treatments
There is no significant difference in cognitive function for patients treated with evolocumab or placebo added to statin therapy

Evolocumab Doesn’t Affect Cognition When Added to Statins

0
No significant between-group difference for patients receiving evolocumab or placebo added to statins
Within a cohort of patients insured through TRICARE

Opioid Rx Frequently Issued for Nonspecific, Spinal Conditions

0
Spine, orthopedic disorders most prominent among categories of conditions linked to initial opioid Rx
Online training for nurses has been found to increase hospital patients' use of venous thromboembolism prophylaxis

Online Nursing Education Can Up Patient Use of VTE Prophylaxis

0
Online training aims to make sure those hospitalized get treatment to prevent venous thromboembolism
The U.S. Food and Drug Administration on Thursday approved Besponsa (inotuzumab ozogamicin) to treat B-cell acute lymphoblastic leukemia.

FDA Approves New Treatment for Acute Lymphoblastic Leukemia

0
For patients with relapsed or refractory B-cell ALL who have received one or two prior treatments
For pregnant women with pre-existing diabetes

Falling Insulin Requirement Linked to Placental Dysfunction

0
FIR ≥15 percent linked to increased risk of composite of clinical markers of placental dysfunction
Antidepressant use is common among U.S. individuals aged 12 years and older

Antidepressants Used by 12.7 Percent of Those Age ≥12 in U.S.

0
Use is higher among females than males; long-term use for one-fourth of those taking antidepressants